ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting
Client Age
Topic Area [clear]
Experience
Course Format
SIG
Instructional Level
Results 61 - 70 of 252
Credit(s): PDHs: 4.5, ASHA CEUs*: 0.45
Summary: These SIG 2 Perspectives articles focus on counseling skills for working with persons with aphasia, “counseling+” activities for patients with mild cognitive impairment and dementia, and resilience in neurorehabilitation. Topics include counseling skills; counseling roles of SLPs; care partner training; and resilience in persons with acquired brain injury, aphasia, dementia, and Alzheimer’s disease.
Presenter(s): Brooke Lang, MA, CCC-SLP; Kyle Mamiya, MS, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: SLPs across work settings face challenges associated with adapting their current evaluation and treatment methods to telepractice. This on demand webinar will discuss adaptations and evidence-based practices for using telepractice to effectively assess and treat individuals with neurogenic communication disorders.
Presenter(s): Richard R Lemoncello, PhD, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: A focus on community re-engagement and return-to-work can provide meaningful and purpose-filled goals related to life participation for adults with acquired brain injury (ABI). This on demand webinar discusses collaborative strategies to engage clients with returning to work and overcoming barriers to community re-engagement. The presenter highlights a model of community-based, return-to-work functional rehabilitation that professionals can adapt in their own local communities.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Presenter(s): Nathan Cornish-Raley, MS, CCC-SLP, CPSP, MSPA; Fernanda Dreux, PhD; Lorinda Kwan-Chen, PhD; Giuseppe Mancini; Luis Riquelme, PhD, CCC-SLP, BCS-S; Chisomo Selemani, PhD,CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This course features a lively discussion with experts in speech-language pathology and telepractice from Australia, Brazil, Hong Kong, Italy, and the U.S. Each panelist describes the practice of speech-language pathology in their respective part of the world, highlights the challenges and modifications required in response to the COVID-19 pandemic, and discusses the inclusion of telepractice in daily service delivery. Panelists also explore the projected impact of remote delivery models on the practice of speech-language pathology worldwide. This course – part of the SIGnature Series – was developed by SIG 17: Global Issues in Communication Sciences and Related Disorders and SIG 18: Telepractice.
Presenter(s): Melissa Newell, AuD, CCC-A, FAAA
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Meniere’s disease (MD) rarely occurs in children. Due to this, care and treatment by knowledgeable clinicians and physicians are lacking. This presentation reviews a case of a 10-year-old male with diagnosed MD, the interdisciplinary approach for care and treatment, the cross-facility approach for obtaining best results, and follow-up hearing aid fitting suggestions for the affected ear. This course was presented and recorded at the 2019 ASHA Convention.
Presenter(s): Jeanane M. Ferre, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Knowing when, why, and who to refer for central auditory evaluation is challenging, particularly in school settings. This session will address questions that professionals who work in schools or with young people may face: Are there “red flags" for a CAPD? What will I know after the evaluation that I don’t already know? Will results change services? Are we “overtesting/over-referring”? Are there ways to provide screening and/or intervention services that align with school-based RtI/MTSS models of intervention? How can schools screen for processing issues in ways that meet students’ needs and use resources efficiently? After screening, what’s next? Are procedures different across work settings? This course is a recorded session from the 2018/2019 online conference “Central Auditory Processing Disorders (CAPD).”
Presenter(s): Elizabeth Adams Costa, PhD; Nancy Mellon, MS; Meredith Ouellette, MS; Colleen Caverly, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Despite advances in hearing technology and intervention, language, academic, and social outcomes in children with hearing loss generally lag behind those of their hearing counterparts. Providing differential diagnoses is challenging, given the cascading effects of auditory deprivation language delays. This presentation identifies commonly occurring comorbid presentations in children with hearing loss and describes the process of effectively making differential diagnoses. This course was presented and recorded at the 2019 ASHA Convention.
Presenter(s): Kyomi Dana Gregory-Martin, PhD, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: When evaluating and treating a client, patient, or student for any type of disorder, audiologists and SLPs need to consider the individual's culture, including the language and dialect they speak. This on demand webinar discusses the acronym MIND (Minority Indigenous Nonstandardized Dialects) and explores the social stigma and unfair treatment individuals often experience due to their language or dialect (known as linguicism).
Presenter(s): Tammy Hopper, PhD, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This on demand webinar presents research evidence and practical examples to help SLPs design person-centered, evidence-based group treatments for individuals with mild to moderate dementia.
<< 3 4 5 6 7 8 9 10 11 12 >>